摘要 |
The invention relates to fragments of Chromogranin A (CgA) derived peptide fragments and their use in methods of therapy, for example in the treatment of diabetes etc. The peptides, for example AL-11, GV-19 and WE-14, are tropic, i.e stimulate release of regulatory substances and may be used in the absence of a stimulatory concentration of glucose. |
申请人 |
THE QUEEN'S UNIVERSITY OF BELFAST;KING'S COLLEGE LONDON;SHAW, CHRISTOPHER;JONES, PETER;PERSAUD, SHANTA;CHEN, TIANBAO;WALKER, BRIAN |
发明人 |
SHAW, CHRISTOPHER;JONES, PETER;PERSAUD, SHANTA;CHEN, TIANBAO;WALKER, BRIAN |